Nadecnemab Biosimilar - Research Grade

Human

GFRA3

5mg/ml

Human IgG4 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH2917

O60609

Blue ice

GFRA3 is a GDNF-family co-receptor implicated in neuronal signalling and the development of specific sensory and sympathetic neurons, making it of interest to neurobiology research. Our research-grade anti-human GFRA3 recombinant monoclonal antibody is an unconjugated, non-therapeutic analog of nadecnemab, intended for research use only (RUO). Manufactured under rigorous in vivo conditions, this low-endotoxin formulation is available in scalable milligram (mg) to gram (g) batches to meet the demands of high-throughput and bulk-usage laboratories. Typical applications include receptor-binding studies, in vitro functional screening, and in vivo neuroscience models requiring a reliable, reproducible reagent.

Detects human GFRA3

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

4 weeks